Risk of Major Malformations Following First-Trimester Exposure to Olanzapine
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000001665
Abstract: Abstract Purpose/Background Since its US Food and Drug Administration approval in 1996, olanzapine has been one of the most commonly prescribed atypical antipsychotics, making a better understanding of its reproductive safety profile critical. The goal… read more here.
Keywords: first trimester; olanzapine; risk major; exposure ... See more keywords
Risk of Major Malformations in Infants After First-Trimester Exposure to Stimulants: Results From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of clinical psychopharmacology"
DOI: 10.1097/jcp.0000000000001702
Abstract: PURPOSE/BACKGROUND The prevalence of attention-deficit/hyperactivity disorder in adult females is 3% to 4%. Attention-deficit/hyperactivity disorder is highly comorbid with other psychiatric disorders such as mood, anxiety, and substance use disorders. For reproductive-aged women, the treatment… read more here.
Keywords: pregnancy registry; first trimester; pregnancy; infants first ... See more keywords
Congenital Malformations in Denmark: Considerations for the Use of Danish Health Care Registries
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Epidemiology"
DOI: 10.2147/clep.s278596
Abstract: Background Danish health registers are used widely to examine associations between specific risk factors and congenital malformations. Various overall prevalence rates of malformations have been reported in Denmark indicating differences in the underlying data sources… read more here.
Keywords: major malformations; danish health; health; malformations denmark ... See more keywords